Also, the lack of orexin, a hypothalamic wakefulness-inducing neuropeptide (Sakurai et al. 1998), affects sleep, feeding and metabolism (Adamantidis and de Lecea 2008) and is associated with increased likelihood of developing obesity (Funato et al. 2009). Here, HCRT is linked to obesity disorder.